1998
DOI: 10.1038/sj.leu.2401032
|View full text |Cite
|
Sign up to set email alerts
|

Acute lymphoblastic leukemia with maturation–a new entity with clinical significance

Abstract: The diagnosis of 'ALL with maturation' (ALLm) is proposed. One hundred and one patients with untreated ALL were entered into this study. The diagnosis of ALLm was made when more than 20% of all nucleated elements in the bone marrow

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2002
2002
2020
2020

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…The subgroup L3 gives a hint of the presence of B-lineage ALL (B-ALL), but again this distinction is not absolute, since occasional B-ALLs display L1/L2 morphology and, conversely, L3-like morphology can be seen in acute non-lymphocytic leukaemia. Rarer morphological variants (see Section 2.2) are "hand-mirror" cell ALL, ALL associated with hypereosinophilia, granulated ALL and ALL with mature cells that are nearly indistinguishable from mature lymphoid neoplasms and require expert observers for accurate identification [15]. The role of cytochemistry (see Section 2.2) is limited to differentiating ALL from myeloid leukaemias.…”
Section: Morphological Classificationmentioning
confidence: 99%
“…The subgroup L3 gives a hint of the presence of B-lineage ALL (B-ALL), but again this distinction is not absolute, since occasional B-ALLs display L1/L2 morphology and, conversely, L3-like morphology can be seen in acute non-lymphocytic leukaemia. Rarer morphological variants (see Section 2.2) are "hand-mirror" cell ALL, ALL associated with hypereosinophilia, granulated ALL and ALL with mature cells that are nearly indistinguishable from mature lymphoid neoplasms and require expert observers for accurate identification [15]. The role of cytochemistry (see Section 2.2) is limited to differentiating ALL from myeloid leukaemias.…”
Section: Morphological Classificationmentioning
confidence: 99%